Investment in Enalare Therapeutics Inc. - Schedule of Equity Method Investments (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2023 USD ($)
Equity Method Investments [Roll Forward]
Acquisition Rights (Other assets), beginning balance	$ 8,125
Acquisition Rights (Other assets), ending balance	8,125
Forward Liability (Accrued expenses and other liabilities, beginning balance	(4,063)
Investment in Enalare Therapeutics, Inc.
Equity Method Investments [Roll Forward]
Non-RDFV Investment (Other assets), beginning balance	8,438
Non-RDFV Investment (Other assets), additions during period	8,514
Non-RDFV Investment (Other assets), ending balance	16,952
Acquisition Rights (Other assets), beginning balance	8,125
Acquisition Rights (Other assets), additions during period	0
Acquisition Rights (Other assets), ending balance	8,125
Forward Liability (Accrued expenses and other liabilities, beginning balance	(4,063)
Forward Liability (Accrued expenses and other liabilities, adjustments	77
Forward Liability (Accrued expenses and other liabilities, additions during period	3,986
Forward Liability (Accrued expenses and other liabilities, ending balance	0
Beginning balance	12,500
Adjustments	77
Additions / Adjustments during period	12,500
Ending balance	$ 25,077